Skip to content
Trial Eligibility
Menu

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

NCT07330258

This study is recruiting at 7 US sites in 6 states, according to its ClinicalTrials.gov record last updated .

Summary

This is an observational study in which data are collected and studied from Parkinson's disease patients who have movement symptoms despite taking standard Parkinson's medications. In observational studies, observations are made without any changes to the participant's healthcare or treatment plan. No investigational product will be administered in this study, as participants will be treated with the standard of care that medical experts currently consider most appropriate.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Parkinson's Disease

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
45 to 75 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Bayer
Last updated on ClinicalTrials.gov
September 4, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 1

  • Banner Alzheimer's Institute (BAI)-Phoenix · Phoenix, AZ

California · 2

  • The Parkinson's & Movement Disorder Institute · Fountain Valley, CA
  • Keck School of Medicine · Los Angeles, CA

Florida · 1

  • Baptist Health Miami Neuroscience Institute · Miami, FL

Georgia · 1

  • Medical College of Georgia at Augusta University · Augusta, GA

New York · 1

  • University of Buffalo Jacobs School of Medicine · Williamsville, NY

Virginia · 1

  • University of Virginia · Charlottesville, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.